We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
17 hedge funds and large institutions have $683K invested in Cyclo Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
21% more funds holding
Funds holding: 14 → 17 (+3)
6% less capital invested
Capital invested by funds: $725K → $683K (-$42.4K)
Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.3K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$19.8K |
| 3 |
VF
Virtu Financial
New York
|
+$16.5K |
| 4 |
State Street
Boston,
Massachusetts
|
+$6K |
| 5 |
JP Morgan Chase
New York
|
+$369 |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$28K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$6.15K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$4.37K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$569 |
